These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4156763)

  • 41. Effects of schedules of reinforcement on brain catecholamine metabolism in the rat.
    Albert LH; Emmett-Oglesby M; Seiden LS
    Pharmacol Biochem Behav; 1977 May; 6(5):481-6. PubMed ID: 896886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cerebellar ataxic rat produced by kainic acid and changes in concentration and turnover rates of catecholamines in discrete brain regions.
    Niimi M; Takahara J; Aoki Y; Fujino H; Ofuji T
    Acta Med Okayama; 1982 Jun; 36(3):223-7. PubMed ID: 7113747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of morphine on the turnover of brain catecholamines and serotonin in rats-chronic morphine administration.
    Theiss P; Papeschi R; Herz A
    Eur J Pharmacol; 1975 Dec; 34(2):263-71. PubMed ID: 791659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of amantadine on motor activity and catalepsy in rats.
    Maj J; Sowińska H; Baran L
    Psychopharmacologia; 1972; 24(2):296-307. PubMed ID: 5064006
    [No Abstract]   [Full Text] [Related]  

  • 47. Further studies on the mode of action of amantadine.
    Strömberg U; Svensson TH
    Acta Pharmacol Toxicol (Copenh); 1971; 30(3):161-71. PubMed ID: 5171936
    [No Abstract]   [Full Text] [Related]  

  • 48. The action of (-) deprenyl on monoamine turnover rate in rat brain.
    Zsilla G; Knoll J
    Adv Biochem Psychopharmacol; 1982; 31():211-7. PubMed ID: 6805258
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):242-53. PubMed ID: 4363855
    [No Abstract]   [Full Text] [Related]  

  • 50. The effect of beta-phenethylamine on noradrenaline and dopamine turnover in rat brain.
    Jackson DM; Smythe DB
    J Pharm Pharmacol; 1974 Jun; 26(6):456-8. PubMed ID: 4154993
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.
    Scheel-Krüger J
    Eur J Pharmacol; 1971; 14(1):47-59. PubMed ID: 4396660
    [No Abstract]   [Full Text] [Related]  

  • 52. Prolyl-leucyl-glycinamide (PLG); regional effects on alpha-MPT-induced catecholamine disappearance in rat brain.
    Versteeg DH; Tanaka M; De Kloet ER; Van Ree JM; De Wied D
    Brain Res; 1978 Mar; 143(3):561-6. PubMed ID: 647380
    [No Abstract]   [Full Text] [Related]  

  • 53. Tissue catecholamines and daily rhythm of liver microsomal enzyme activity.
    Jori A; Caccia S; Salle ED
    Eur J Pharmacol; 1973 Jan; 21(1):37-40. PubMed ID: 4709202
    [No Abstract]   [Full Text] [Related]  

  • 54. Environmental stress as a factor in the response of rat brain catecholamine metabolism to delta8-tetrahydrocannabinol.
    MacLean KI; Littleton JM
    Eur J Pharmacol; 1977 Jan; 41(2):171-82. PubMed ID: 832673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
    Symchowicz S; Korduba CA; Veals J
    Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
    [No Abstract]   [Full Text] [Related]  

  • 56. The serotonergic system in the brain and its possible functional connections with other aminergic systems.
    Samanin R; Garattini S
    Life Sci; 1975 Oct; 17(8):1201-9. PubMed ID: 574
    [No Abstract]   [Full Text] [Related]  

  • 57. Passive avoidance performance correlates with catecholamine turnover in discrete limbic brain regions.
    Kovács GL; Versteeg DH; de Kloet ER; Bohus B
    Life Sci; 1981 Mar; 28(10):1109-16. PubMed ID: 6112649
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.
    Berger T; Lemmer B
    Pol J Pharmacol Pharm; 1976; 28(6):601-3. PubMed ID: 1012983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
    Maj J; Sowińska H; Baran L; Sarnek J
    Eur J Pharmacol; 1974 Apr; 26(1):9-14. PubMed ID: 4857604
    [No Abstract]   [Full Text] [Related]  

  • 60. Evidence for depressed catecholamine and enhanced serotonin metabolism in aging male rats: posssible relation to gondotropin secretion.
    Simpkins JW; Mueller GP; Huang HH; Meites J
    Endocrinology; 1977 Jun; 100(6):1672-8. PubMed ID: 870310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.